Postantibiotic effects and postantibiotic sub-MIC effects of erythromycin, roxithromycin, tilmicosin, and tylosin on Pasteurella multocida

International Journal of Antimicrobial Agents

Volumn 17, Issue 6, 2001, Pages 471-476

  Lim, Jong hwan ^a   Yun, Hyo in ^a  

^a Chungnam National University   (South Korea)

Author keywords

Macrolides; Postantibiotic effect; Roxithromyicin; Tilmicosin

Indexed keywords

ERYTHROMYCIN; ROXITHROMYCIN; TILMICOSIN; TYLOSIN;

ARTICLE; BACTERIAL GROWTH; CONTROLLED STUDY; DRUG EFFECT; NONHUMAN; PASTEURELLA MULTOCIDA; POSTANTIBIOTIC EFFECT; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROMYCIN; HUMANS; MACROLIDES; MICROBIAL SENSITIVITY TESTS; PASTEURELLA INFECTIONS; PASTEURELLA MULTOCIDA; ROXITHROMYCIN; TYLOSIN;

EID: 0034985596     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(01)00328-4     Document Type: Article

References (31)

1. Progressive and nonprogressive atrophic rhinitis
2. In vitro activities of azithromycin (CP 62993), clathromycin (A-56268; TE-031), erythromycin, roxithromycin and clindamycin
3. Comparative in vitro potencies of nine new macrolides
4. In vitro evaluation of three new macrolide antimicrobial agents, RU 28965, RU 29065 and RU 29702, and comparison with other orally administered drugs
5. In vitro comparison of the activity of RU289656, a new macrolide, with that of erythromycin against aerobic and anaerobic bacteria
6. In vitro antibacterial properties EL-870, a new semi-synthetic macrolide antibiotic
7. Postantibiotic and physiological effects of tilmicosin, tylosin, and apramycin at subminimal and suprainhibitory concentrations on some swine and bovine respiratory tract pathogens
8. In vitro varieties? Antimicrobial susceptibility tests and their clinical relevance
9. Subinhibitory concentrations of antibiotics
10. Antibiotic levlels in experimentally infected mice in relation to therapeutic effect and antibacterial activity in vitro
11. Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model
12. In vivo postantibiotic effect in a thigh infection in neutropenic mice
13. Postantibiotic sub-MIC effects of vancomycin, roxithromycin, sprafloxacin, and amikacin
14. The slow recovery of bacteria from the toxic effects of penicillin
15. The action of penicillin on staphylococcus
16. A new method to determine postantibiotic effects and effects of subinhibitory antibiotic concentrations
17. An in vitro model for monitoring bacterial responses to antibiotic agents under simulated in vivo conditions
18. Comparison of two methods for determining in vitro postantibiotic effects of three antibiotics on Escherichia coli
19. Susceptibility testing of antimicrobials in liquid media
20. Comparative in vitro activities of new 14-, 15- and 16-memberd macrolides
21. Abnormal forms of bacteria produced by antibiotics
22. Targets of penicillin action in Escherichia coli
23. Enhanced phagocytosis of encapsulated Escherichia coli strains after exposure to sub-MICs of antibiotics is correlated to changes of the bacterial cell surface
24. Decrease in adhesion of E. coli to human urinary tract epithelial cells in vitro by subinhibitory concentrations of ampicillin
25. Effect of subinhibitory concentrations of antibiotics on the adhesion of Streptococcus pyogenes to pharyngeal epithelial cells
26. Effects of low antibiotic concentrations on bacteria
27. Potentiation of opsonization and phagocytosis of Streptococcus pyogenes following growth in the presence of clindamycin
28. Enhanced killing of penicillin-treated gram-positive cocci by human granulocytes: role of bacterial autolysins, catalase and granulocyte oxidative pathways
29. Antibiotics and phagocytosis
30. Interactions between antibiotics and human neutrophils in the killing of staphylococci. Studies with normal and cytochalasin b-treated cells
31. Postantibiotic leucocyte enhancement: increased susceptibility of bacteria pretreated with antibiotics to activity of leucocytes